3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
3
Leukemia, Myeloid, Acute
3
Glioblastoma
3
Brain Neoplasms
3
Glioma
2
Thyroid Neoplasms
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Neurologic Manifestations
1
Neoplasms, Neuroepithelial
1
Neoplasm Metastasis
1
Lymphoma
1
Leukemia
1
Head and Neck Neoplasms
1
HTLV-I Infections
1
Gliosarcoma
1
Diffuse Intrinsic Pontine Glioma
1
Breast Neoplasms
1
Astrocytoma
1
Interventions
Magnetic Resonance Spectroscopy
2
Everolimus
2
Erlotinib Hydrochloride
2
ribociclib
1
palbociclib
1
olaparib
1
etoposide phosphate
1
erdafitinib
1
X-Rays
1
Sunitinib
1
Specimen Handling
1
Radiotherapy
1
Phantoms, Imaging
1
Nuclear Medicine Department, Hospital
1
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
1
Microarray Analysis
1
Lapatinib
1
Irinotecan
1
Immunologic Techniques
1
Immunohistochemistry
1
Immunoglobulin G
1
Ifosfamide
1
Fluorodeoxyglucose F18
1
Etoposide
1
Donepezil
1
Disulfides
1
Dasatinib
1
Cyproheptadine
1
Carboplatin
1
Blotting, Western
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Familial ependymoma
×
Valproic Acid
×
Clear all
No trials found.